Filing Flows › Aspira Women's Health (AWHL) › Q2 2026 › vs Q2 2025
Aspira Women's Health (AWHL) Q2 2026 vs Q2 2025 (year over year)
Aspira Women's Health's revenue fell $358K (-15%) from $2.4M in Q2 2025 to $2.0M in Q2 2026.
Aspira Women's Health, Q2 2026: revenue $2.0M (-15% year over year), operating margin -89.7%, net loss $2.4M, operating cash flow −$2.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.0M | $2.4M | −$358K | -15% |
| Net loss | $2.4M | $2.7M | −$246K | -9% |
| Costs & expenses | $4.5M | $5.1M | −$604K | -12% |
| Operating costs | $3.9M | $4.2M | −$333K | -8% |
| Interest & other, net | $585K | $856K | −$271K | -32% |
| Cost of revenue | $915K | $870K | $45K | +5% |
| Research & development | $692K | $704K | −$12K | -2% |
| Sales & marketing | $567K | $679K | −$112K | -16% |
| General & admin | $1.7M | $2.0M | −$254K | -13% |
| Operating cash sources | $2.4M | $2.7M | −$246K | -9% |
| Depreciation & amortization | $40K | $11K | $29K | +264% |
| Share-based compensation | $19K | $16K | $3K | +19% |
| Working capital & other | $351K | $905K | −$554K | -61% |
| Cash used in operations | $2.0M | $1.7M | $276K | +16% |
| Net loss absorbed | $2.4M | $2.7M | −$246K | -9% |
Questions
How much did Aspira Women's Health's revenue grow year over year in Q2 2026?
Aspira Women's Health's revenue fell $358K (-15%) from $2.4M in Q2 2025 to $2.0M in Q2 2026.